Oncoinvent ASA

Oncoinvent ASA is a Norwegian biotechnology company dedicated to developing innovative cancer treatments. Its primary aim is to improve the prognosis and quality of life for cancer patients by leveraging novel therapeutic approaches. Operating within the pharmaceutical and biotechnology sector, Oncoinvent ASA focuses on developing next-generation cancer immunotherapies. Its research aims to create treatments that target tumour cells and modulate the immune system, offering potential breakthroughs in cancer care. Keep up to date on the latest share price changes by adding ONCIN.OL stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.